Literature DB >> 23166291

Cardiovascular disease after Escherichia coli O157:H7 gastroenteritis.

Patricia Hizo-Abes1, William F Clark, Jessica M Sontrop, Ann Young, Anjie Huang, Heather Thiessen-Philbrook, Peter C Austin, Amit X Garg.   

Abstract

BACKGROUND: Escherichia coli O157:H7 is one cause of acute bacterial gastroenteritis, which can be devastating in outbreak situations. We studied the risk of cardiovascular disease following such an outbreak in Walkerton, Ontario, in May 2000.
METHODS: In this community-based cohort study, we linked data from the Walkerton Health Study (2002-2008) to Ontario's large healthcare databases. We included 4 groups of adults: 3 groups of Walkerton participants (153 with severe gastroenteritis, 414 with mild gastroenteritis, 331 with no gastroenteritis) and a group of 11 263 residents from the surrounding communities that were unaffected by the outbreak. The primary outcome was a composite of death or first major cardiovascular event (admission to hospital for acute myocardial infarction, stroke or congestive heart failure, or evidence of associated procedures). The secondary outcome was first major cardiovascular event censored for death. Adults were followed for an average of 7.4 years.
RESULTS: During the study period, 1174 adults (9.7%) died or experienced a major cardiovascular event. Compared with residents of the surrounding communities, the risk of death or cardiovascular event was not elevated among Walkerton participants with severe or mild gastroenteritis (hazard ratio [HR] for severe gastroenteritis 0.74, 95% confidence interval [CI] 0.38-1.43, mild gastroenteritis HR 0.64, 95% CI 0.42-0.98). Compared with Walkerton participants who had no gastroenteritis, risk of death or cardiovascular event was not elevated among participants with severe or mild gastroenteritis.
INTERPRETATION: There was no increase in the risk of cardiovascular disease in the decade following acute infection during a major E. coli O157:H7 outbreak.

Entities:  

Mesh:

Year:  2012        PMID: 23166291      PMCID: PMC3537814          DOI: 10.1503/cmaj.112161

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  38 in total

1.  Validity of information on comorbidity derived rom ICD-9-CCM administrative data.

Authors:  Hude Quan; Gerry A Parsons; William A Ghali
Journal:  Med Care       Date:  2002-08       Impact factor: 2.983

2.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

Authors:  R A Deyo; D C Cherkin; M A Ciol
Journal:  J Clin Epidemiol       Date:  1992-06       Impact factor: 6.437

3.  The accuracy of Medicare's hospital claims data: progress has been made, but problems remain.

Authors:  E S Fisher; F S Whaley; W M Krushat; D J Malenka; C Fleming; J A Baron; D C Hsia
Journal:  Am J Public Health       Date:  1992-02       Impact factor: 9.308

Review 4.  The relationship between infection, inflammation, and cardiovascular disease: an overview.

Authors:  G D Lowe
Journal:  Ann Periodontol       Date:  2001-12

5.  Simulation study of confounder-selection strategies.

Authors:  G Maldonado; S Greenland
Journal:  Am J Epidemiol       Date:  1993-12-01       Impact factor: 4.897

6.  Direct cytotoxic action of Shiga toxin on human vascular endothelial cells.

Authors:  T G Obrig; P J Del Vecchio; J E Brown; T P Moran; B M Rowland; T K Judge; S W Rothman
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

7.  Impact of infectious burden on extent and long-term prognosis of atherosclerosis.

Authors:  Christine Espinola-Klein; Hans J Rupprecht; Stefan Blankenberg; Christoph Bickel; Helmuth Kopp; Gerd Rippin; Anja Victor; Gerd Hafner; Wolfgang Schlumberger; Jürgen Meyer
Journal:  Circulation       Date:  2002-01-01       Impact factor: 29.690

8.  Shiga toxin-associated hemolytic-uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1 beta, and tumor necrosis factor alpha on human vascular endothelial cells in vitro.

Authors:  C B Louise; T G Obrig
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

9.  Endothelial heterogeneity in Shiga toxin receptors and responses.

Authors:  T G Obrig; C B Louise; C A Lingwood; B Boyd; L Barley-Maloney; T O Daniel
Journal:  J Biol Chem       Date:  1993-07-25       Impact factor: 5.157

10.  Molecular basis for high renal cell sensitivity to the cytotoxic effects of shigatoxin-1: upregulation of globotriaosylceramide expression.

Authors:  Alisa K Hughes; Zuhal Ergonul; Peter K Stricklett; Donald E Kohan; Z Ergonal
Journal:  J Am Soc Nephrol       Date:  2002-09       Impact factor: 10.121

View more
  4 in total

Review 1.  Role of gut microbiota in atherosclerosis.

Authors:  Annika Lindskog Jonsson; Fredrik Bäckhed
Journal:  Nat Rev Cardiol       Date:  2016-12-01       Impact factor: 32.419

2.  Antibiotics for secondary prevention of coronary heart disease.

Authors:  Naqash J Sethi; Sanam Safi; Steven Kwasi Korang; Asbjørn Hróbjartsson; Maria Skoog; Christian Gluud; Janus C Jakobsen
Journal:  Cochrane Database Syst Rev       Date:  2021-02-23

3.  Risk of Acute Myocardial Infarction in Patients with Gastroenteritis: A Nationwide Case-Control Study.

Authors:  Ying-Hsuan Tai; Ming-Long Chang; Pao-Hsien Chu; Chun-Chieh Yeh; Yih-Giun Cherng; Ta-Liang Chen; Chien-Chang Liao
Journal:  J Clin Med       Date:  2022-02-28       Impact factor: 4.241

4.  Therapeutic administration of the chemokine CXCL1/KC abrogates autoimmune inflammatory heart disease.

Authors:  Kurt Bachmaier; Sophie Toya; Asrar B Malik
Journal:  PLoS One       Date:  2014-02-27       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.